Dr. Bo Heinemann

Dr. Bo Heinemann has a diverse work experience spanning over two decades. Dr. Bo started their career as a Masters student at Carlsberg Laboratorium in 1995. Dr. Bo then went on to work as a Pre Doctoral Fellow at the University of Oxford in 1996. Dr. Heinemann later joined the Max Planck Institute for Biophysics as a Post Doc from 1999 to 2001. Dr. Bo then moved to REVOTAR Biopharmaceuticals AG, where they held the position of Head of Laboratory, Biology for almost 9 years. At REVOTAR, they were responsible for various aspects of drug discovery, including compound-library handling, biophysical compound profiling, and in-vitro assays. In 2010, Dr. Heinemann joined EpiTherapeutics ApS as a Senior scientist, where they managed the development of biochemical assays for drug discovery. Dr. Bo then worked at Gubra from 2015 to 2018, serving as Group Leader, Assays and later as Principal Scientist. Currently, Dr. Heinemann is working at BioInnovation Institute, where they hold the roles of Head of Facilities and Laboratory Manager.

Dr. Bo Heinemann completed their education in a chronological order, with their most recent degree being a Doctor of Philosophy (Ph.D.) in Molecular Biology from Mainz University. Dr. Bo pursued their Master's degree in Chemistry/Molecular Biology from Roskilde University, which they completed from 1988 to 1995. Currently, there is no information available about their education at Fuglevangsvej, including the start year, end year, degree name, or field of study.